Clinical Trials Logo

Filter by:
NCT ID: NCT01104909 Completed - Blood Pressure Clinical Trials

How to Get a Better Dry Weight in End-stage Renal Disease (ESRD) Population for Improving Blood Pressure Control

Start date: April 2008
Phase: N/A
Study type: Interventional

End-stage renal disease (ESRD) is a common clinical condition. In this population, the prevalence of systemic hypertension is high and its adequate control can determinate the outcome. The first step for a good control of blood pressure in renal patients is adjusting his/her dry weight. Actually, dry weight is assessed based on clinical examination and blood pressure. The electrical bioimpedance is a simple and portable device. The investigators design a randomized clinical trial for evaluating two ways of getting the best dry weight for hemodialysis patients. A basal 24h ABPM will be taken before the randomization. Then, 2 weeks later the dry weight be revised, the investigators will get a second 24h ABPM.

NCT ID: NCT01103648 Completed - Inflammation Clinical Trials

Effect of Simvastatin and Ezetimibe on Lipid and Inflammation

Start date: June 2005
Phase: N/A
Study type: Interventional

Ezetimibe specifically blocks the absorption of dietary and biliary cholesterol and plant sterols. Synergism of ezetimibe-statin therapy on LDL-cholesterol has been demonstrated, but data concerning the pleiotropic effects of this combination are controversial. We tested the hypothesis that the combination of simvastatin and ezetimibe would induce improvement in inflammatory status, as reflected by leukocyte count and CRP, IL-6 and TNF-a levels. This open-label trial evaluated whether this combination results in a synergistic effect the pro-inflammatory status of pre-diabetic subjects. Fifty pre-diabetic subjects were randomly assigned to one of 2 groups, one receiving ezetimibe (10 mg/d), the other, simvastatin (20 mg/d) for 12 weeks, followed by an additional 12-week period of combined therapy.

NCT ID: NCT01103518 Active, not recruiting - Dysmenorrhea Clinical Trials

Ethinyl Estradiol and Cyproterone Acetate in Irregular Menstruation

Start date: December 2009
Phase: Phase 4
Study type: Interventional

This is a Phase IV, randomized, double-blind, comparative study of the use of two preparations of ethinyl estradiol and cyproterone acetate in the treatment of menstrual irregularities of hyper-androgenic origin.

NCT ID: NCT01103323 Completed - Clinical trials for Metastatic Colorectal Cancer

Patients With Metastatic Colorectal Cancer Treated With Regorafenib or Placebo After Failure of Standard Therapy

Start date: April 2010
Phase: Phase 3
Study type: Interventional

This is a randomized, double-blind, placebo-controlled multi-center phase III study to evaluate efficacy and safety of regorafenib in patients with metastatic colorectal cancer (CRC) who have progressed on/after all approved drugs for CRC

NCT ID: NCT01102959 Unknown status - Diabetes Mellitus Clinical Trials

The Effectiveness of Photographic Educational Material on Carbohydrate Counting for Adolescents With Diabetes

Start date: March 2010
Phase: N/A
Study type: Interventional

The hypothesis of this study focuses on obtaining accurate information on the effectiveness of photographic educational material on orientation of carbohydrate counting for adolescents with diabetes.

NCT ID: NCT01102946 Completed - Clinical trials for Diabetic Retinopathy

Panretinal Photocoagulation (PRP) Plus Ranibizumab for Proliferative Diabetic Retinopathy

IRaHi
Start date: February 2009
Phase: Phase 2
Study type: Interventional

The purpose of this study is to evaluate the effects of panretinal photocoagulation plus intravitreal ranibizumab for the treatment of patients with high risk proliferative diabetic retinopathy in terms of changes in visual acuity and neovascularization area.

NCT ID: NCT01102621 Completed - Hearing Loss Clinical Trials

Hearing Loss and Complaint in Patients With Head and Neck Cancer Treated With Radiotherapy

Start date: January 2005
Phase: N/A
Study type: Observational

Hypothesis: Treatment for head and neck tumors often involve methods that affect the auditory system and cause hearing loss. Neck dissection negatively impacts the lymphatic drainage, chemotherapy uses ototoxic drugs, radiotherapy affects blood flow and tissue radiation is toxic to the ear and may lead to hearing losses of various types and degrees. Objective: To investigate occurrences of hearing loss and complaints among patients with head and neck tumors who underwent radiotherapy. Study design: Prospective, case-control study. Setting: Tertiary care center hospital. Subjects and Methods: 282 subjects were evaluated, 141 with head and neck tumors and 141 as an age-matched control group. The controls had never undergone oncological treatment that put their hearing at risk. All subjects underwent audiological evaluation, including the HHIE questionnaire, pure tone audiometry, speech audiometry and immittance audiometry. The radiation dose received by the auditory system was calculated based on the percentage of the external auditory canal included in the radiation field.

NCT ID: NCT01101425 Active, not recruiting - Breast Cancer Clinical Trials

Male Breast Cancer: Understanding the Biology for Improved Patient Care

Start date: December 2010
Phase:
Study type: Observational [Patient Registry]

Rationale: Gathering medical information and tumor samples from patients with male breast cancer may help doctors learn more about the disease. Purpose retrospective part: to perform a large international retrospective analysis of clinical and biological data of male BC patients treated in the participating centers from 1990 to 2010. Purpose prospective part: to create a registry of men with breast cancer for a period of 30 months (starting early 2014).

NCT ID: NCT01100645 Not yet recruiting - Insomnia Clinical Trials

Efficacy and Safety of the Herbal Medicine Sominex ® (Passiflora Incarnata L., Valeriana Officinalis L. and Crataegus Oxyacantha L.), Manufactured by the Laboratory EMS S / A in Patients With Psychophysiological Insomnia

Start date: October 2010
Phase: Phase 3
Study type: Interventional

The main objective of this study is to evaluate the clinical efficacy of the drug Sominex (Valeriana officinalis L., 40 mg, 30 mg Crataegus oxyacantha L. and Passiflora incarnata L. 50 mg) manufactured by the Laboratory EMS S / A, compared to placebo in improving sleep efficiency, based on the response of the sleep quality questionnaire (MSQ) and polysomnographic parameters described below: - Latency to onset of sleep; - Total time of sleep; - Rapid eye movement (REM) sleep latency; - Duration of REM sleep

NCT ID: NCT01100541 Completed - Thermotherapy Clinical Trials

Evaluation of a Polymeric Plate Derived From Castor Oil to Thermotherapy

Start date: February 2010
Phase: N/A
Study type: Interventional

The objective of this work is to evaluate, from volunteers viewpoint, the usability, comfort, appearance, weight, superficial temperature, and other characteristics of a polymeric plate derived from castor oil developed to thermotherapy. The volunteers will use polymeric plate as a therapeutic resource in the shoulder area and then fill in, without interference of the researcher, some questions about the characteristics of interest.